Lonza, Basel, Switzerland, has announced the World Intellectual Property Organization (WIPO) published its International Patent Application WO 2011/038898 for Larch Arabinogalactan (LAG), the key component in the immune ingredient ResistAid. The application titled “Arabinogalactan for Enhancing the Adaptive Immune Response” contains patent claims relating to LAG’s positive effect on the adaptive arm of the immune system prior to, during and after exposure to foreign antigens. Furthermore, the application claims potential use in a vaccination kit comprising a composition with Arabinogalactan and a vaccine.